Allocating treatment resources for hepatitis C in the UK: a constrained optimization modelling approach
Background and objective: Although the treatment of chronic hepatitis C (CHC) has significantly evolved with the introduction of direct-acting antivirals, the treatment uptake rates have been low especially among marginalized groups in the UK, such as people who inject drug (PWID) and men who have s...
Saved in:
Main Authors: | Ru Han (Author), Shuyao Liang (Author), Clément François (Author), Samuel Aballea (Author), Emilie Clay (Author), Mondher Toumi (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2021-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Commentary on "Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial" by Gautret et al
by: Mondher Toumi, et al.
Published: (2020) -
Systematic review of utility values used in the pharmacoeconomic evaluations for schizophrenia: implications on cost-effectiveness results
by: Junwen Zhou, et al.
Published: (2019) -
An overview of health technology assessments of gene therapies with the focus on cost-effectiveness models
by: Michał Pochopień, et al.
Published: (2021) -
Measuring health-related quality of life in young children: how far have we come?
by: Nicola Germain, et al.
Published: (2019) -
Cost-Effectiveness Analysis of Innovative Therapies for Patients with Non-Alcoholic Fatty Liver Disease
by: Michal Pochopien, et al.
Published: (2024)